
Use of steroids in Ophthalmology
04 January 2024
Inflammatory eye diseases present significant challenges in the ophthalmological setting, but steroids have emerged as essential tools in the management of these conditions. Its ability to reduce inflammation and modulate immune responses has led to its application in various inflammatory pathologies of the eye, marking notable advances in ophthalmological treatment.
Uveitis, characterized by inflammation of the uvea, responds positively to steroid treatment. Eye drops and intraocular injections are used to control inflammation and prevent serious complications, such as damage to the retina.
In cases of scleritis, an inflammation of the sclera, steroids can be administered locally to reduce inflammation and relieve pain. This application contributes significantly to the management of a condition that can affect eye structure and vision.
In autoimmune diseases that affect the eye, such as rheumatoid arthritis or systemic lupus erythematosus, steroids play a crucial role in controlling the dysregulated immune response that contributes to ocular inflammation.
Personalization of treatment is essential, adapting the dose and duration of steroid use according to the severity of the disease and the patient's response. Continuous monitoring, including assessment of intraocular pressure, is crucial to detect potential side effects, such as elevation of intraocular pressure.
Despite the benefits of steroid use in ophthalmology, persistent challenges include the need for strategies that minimize long-term side effects, such as cataract formation or the development of glaucoma.